2014
DOI: 10.1111/nan.12056
|View full text |Cite
|
Sign up to set email alerts
|

Phosphatidylinositol‐4,5‐bisphosphate is enriched in granulovacuolar degeneration bodies and neurofibrillary tangles

Abstract: AimsAmong the pathological findings in Alzheimer’s disease (AD), the temporal and spatial profiles of granulovacuolar degeneration (GVD) bodies are characteristic in that they seem to be related to those of neurofibrillary tangles (NFTs), suggesting a common mechanism underlying the pathogenesis of these structures. Flotillin-1, a marker of lipid rafts, accumulates in lysosomes of tangle-bearing neurones in AD patients. In addition, recent reports have shown that GVD bodies accumulate at the nexus of the autop… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
14
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(16 citation statements)
references
References 33 publications
1
14
0
Order By: Relevance
“…Various patterns of PtdIns(4,5)P2 immunoreactivity are found in pyramidal neurons of individuals with AD and other neurodegenerative diseases Some PtdIns(4,5)P2-immunopositive materials exhibited 3-to 5-lm-diameter vesicular structures with central granules that were surrounded by a halo-like clear zone and an outer membrane, characteristics that are indicative of GVD bodies. CK-1d, a marker of GVD bodies [9,13], was colocalized with PtdIns(4,5)P2, suggesting that PtdIns(4,5)P2 is a constituent of GVD bodies, as previously reported ( Figure 1A) [4]. The other PtdIns(4,5)P2-immunopositive materials exhibited granules that were clustered and piled up like NFTs.…”
Section: Resultssupporting
confidence: 82%
See 1 more Smart Citation
“…Various patterns of PtdIns(4,5)P2 immunoreactivity are found in pyramidal neurons of individuals with AD and other neurodegenerative diseases Some PtdIns(4,5)P2-immunopositive materials exhibited 3-to 5-lm-diameter vesicular structures with central granules that were surrounded by a halo-like clear zone and an outer membrane, characteristics that are indicative of GVD bodies. CK-1d, a marker of GVD bodies [9,13], was colocalized with PtdIns(4,5)P2, suggesting that PtdIns(4,5)P2 is a constituent of GVD bodies, as previously reported ( Figure 1A) [4]. The other PtdIns(4,5)P2-immunopositive materials exhibited granules that were clustered and piled up like NFTs.…”
Section: Resultssupporting
confidence: 82%
“…We previously reported that charged multivesicular body protein 2B (CHMP2B), an endosome-related protein, and cyclin-dependent kinase 5 (CDK5), a tau kinase, are present in GVD bodies [2,3]. We have also revealed that phosphatidylinositol-4,5bisphosphate [PtdIns(4,5)P2], a phospholipid associated with lipid rafts, exhibits identical immunoreactivity in GVD bodies and NFTs [4]. In addition, double immunofluorescence staining revealed that PtdIns(4,5) P2-immunopositive granules within NFTs were not colocalized with phosphorylated tau.…”
Section: Introductionmentioning
confidence: 99%
“…The estimated isoelectric point (pI) of PICALM whole protein (isoform 1 with 652 amino acids) is 7.70 (Goedert et al, 1996). Interestingly, it has been reported that PIP 2 (4,5) is enriched in NFTs and GVDs (Nishikawa et al, 2014). PICALM directly interacts with PIP 2 via its N-terminal ANTH domain (Ford et al, 2001), and PICALM association to NFTs might be driven by this interaction.…”
Section: Discussionmentioning
confidence: 99%
“…Following its local generation, PI(4,5)P 2 activates the ezrin/radixin/moesin proteins required for uropod retraction [30,31]. A co-localization of PI(4,5)P 2 and flotillins was also observed in pathological neuronal structures typical for the brains of Alzheimer's disease patients, suggesting their common involvement in neurodegeneration [136]. Flotillins have also been indicated as regulators of the PI3-kinase/AKT pathway crucial for cancer cell survival [137,138].…”
Section: Flotillins Affect Sphingosine-1-phosphate Signaling and Are mentioning
confidence: 95%